Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bidstrup B. P., Royston D., Sapsford R. N., Taylor K. M. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg. 1989 Mar;97(3):364–372. [PubMed] [Google Scholar]
- Dalton H., Chappel D., Climie R. Thrombolysis for acute myocardial infarction in a district general hospital. J R Soc Med. 1989 Jul;82(7):394–395. doi: 10.1177/014107688908200708. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee K. F., Mandell J., Rankin J. S., Muhlbaier L. H., Wechsler A. S. Immediate versus delayed coronary grafting after streptokinase treatment. Postoperative blood loss and clinical results. J Thorac Cardiovasc Surg. 1988 Feb;95(2):216–222. [PubMed] [Google Scholar]
- O'Neill W. W., Topol E. J., Pitt B. Reperfusion therapy of acute myocardial infarction. Prog Cardiovasc Dis. 1988 Jan-Feb;30(4):235–266. doi: 10.1016/0033-0620(88)90018-7. [DOI] [PubMed] [Google Scholar]
- Rentrop K. P. Thrombolytic therapy in patients with acute myocardial infarction. Circulation. 1985 Apr;71(4):627–631. doi: 10.1161/01.cir.71.4.627. [DOI] [PubMed] [Google Scholar]
- Sobel B. E., Gross R. W., Robison A. K. Thrombolysis, clot selectivity, and kinetics. Circulation. 1984 Aug;70(2):160–164. doi: 10.1161/01.cir.70.2.160. [DOI] [PubMed] [Google Scholar]
- Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs. 1985 Mar;29(3):236–261. doi: 10.2165/00003495-198529030-00003. [DOI] [PubMed] [Google Scholar]
- van Oeveren W., Jansen N. J., Bidstrup B. P., Royston D., Westaby S., Neuhof H., Wildevuur C. R. Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. Ann Thorac Surg. 1987 Dec;44(6):640–645. doi: 10.1016/s0003-4975(10)62153-4. [DOI] [PubMed] [Google Scholar]